Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2011-10-17 Capital/Financing Update
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Appendix 3B 7 pages 52.7KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules and the Corporations Act, indicating it is a regulatory filing related to securities issuance. It details the issuance of ordinary shares and options under a Performance Rights Plan, including number of securities, issue price, and terms. The document is a formal announcement of new securities issued and application for quotation on the ASX. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an announcement of a capital market transaction. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2011-10-17 English
Annual Report to shareholders 132 pages 3.3MB
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2010-2011' for CSL Limited and contains detailed financial results, business highlights, dividends, sales by region and product, management commentary, and comprehensive financial statements sections such as Directors' Report, Auditor's Independence Declaration, Consolidated Statements, Notes to Financial Statements, Directors' Declaration, and Independent Auditor's Report. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes detailed financial data and analysis for the fiscal year ended 30 June 2011, consistent with an official yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K).
2011-09-15 English
Notice of Annual General Meeting/Proxy Form 17 pages 992.8KB
Regulatory Filings
2011-09-15 English
Appendix 3B 7 pages 53.0KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class and number of securities issued, issue price, purpose, and quotation application to the ASX. It references specific ASX rules and includes sections on securities ranking, dividend policy, and quotation agreements. The document is a formal announcement related to new share issues and capital changes, not a financial report or earnings release. It fits the definition of a 'Share Issue/Capital Change' announcement, which covers new share issues and related capital structure changes.
2011-09-13 English
Ceasing to be a substantial holder 12 pages 35.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Notice of Person Ceasing to be a Substantial Shareholder under Section 671B of the Corporations Act 2001, specifically a Form 605. It details changes in shareholding by The Capital Group Companies, Inc. in CSL Limited, including dates, share quantities, and associated nominee lists. The content is regulatory in nature, reporting changes in substantial shareholdings, and does not contain financial statements, earnings data, or management commentary. It is not an announcement of a report but a formal regulatory filing about shareholding changes. Therefore, the document fits the category of Major Shareholding Notification (MRQ).
2011-09-06 English
Change of Director`s Interest Notice 2 pages 27.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details the change in shareholdings of a company director, including the number of shares acquired, disposed, and held before and after the change. The document is a formal notification of a director's personal share transactions, specifically insider trades. It does not contain financial performance data, management discussion, or other report content. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 3425 characters, which is consistent with a detailed insider trading notice rather than a full report or announcement of a report.
2011-09-01 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.